Abstract:The present study systematically studied the intravenous injectable formulation of liposomes loaded with levofloxacin, an amphipathic antibiotic. The aim of the present study was to design passive targeting liposomes, which might improve the antibacterial activity by accumulating in lung and reduce side effects such as neurotoxicity and hematotoxicity associated with direct injection of the drug. Levofloxacin-loaded liposomes were prepared by the ammonium sulfate gradients method. The formulated liposomes were found to be relatively uniform in size (7.424 +/- 0.689 mu m) with a positive zeta potential (+13.11 +/- 1.08 mV). The entrapment efficiency of levofloxacin-loaded liposomes ranged from 82.19% to 86.23%. The administered liposomes were composed of soybean phosphatides, cholesterol, levofloxacin, and sulfate which existed in inner liposomes. In vitro drug release was monitored for up to 3 days, and the release behavior Was in accordance with the Weibull equation. The levofloxacin-loaded liposomes exhibited a longer elimination half-life (t(1/2 beta)) in vivo compared with the levofloxacin solution after intravenous injection to New Zealand rabbits. The encapsulation of levofloxacin in liposomes also changed its biodistribution in mice after intravenous injection in caudal vein. Liposomal levofloxacin performed significant lung targeting efficiency with area under the concentration-time curve, targeting efficacy (Te), and The intake rate (Re) of lung, all showing obvious increase. In addition, liposomal formulations presented accumulative activity in :spleen and liver. Conversely, the biodistribution of liposomal formulation in non-RES sites, such as kidney, brain, heart, and plasma, decreased with descending peak concentration ration (Ce) compared to levo-floxacin injection, which potentially resulted in the reduction of the side effects of free drug. These results Indicated that the levofloxacin-loaded liposomes were promising passive targeting to lung for pulmonary Infection treatment.

Study on Encapsulation Efficiency and In vitro Release Profile of Levofloxacin Hydrochloride Liposome

In Vitro and in Vivo Evaluation of Levofloxacin Sustained-Release Capsules.

Study on the Preparation and Characterization of the Levofloxacin Hydrochloride and Chitosan Membrane

The Formulation of Epirubicin Hydrochloride Long-Circulating Thermosensitive Liposomes and Drug Re-lease in Vitro

Preparation of Soybean Lecithin Azithromycin Liposome and Study on Its Leakage

Percutaneous penetration of levofloxacin lactate liposome gel

Preparation and characterization of PEG coating levofloxacin-liposomes

Chitosan-coated liposome with lysozyme-responsive properties for on-demand release of levofloxacin

Prolonged systemic delivery of antibacterial agent levofloxacin using liposomes

Study on Encapsulation Efficiency and In-vitro Release of Glycyrrhetinic Acid Liposomes

Study on Encapsulation Efficiency and in Vitro Release of Baicalin Liposomes

Pharmacokinetics of Levofloxacin Hydrochloride Soft Capsules, Hard Capsules and Tablets in Chinese Healthy Volunteers

Preparation of oxaliplatin liposome and in vitro drug-release

Targeted delivery of levofloxacin-liposomes for the treatment of pulmonary inflammation.

Determination of Contents of Functional Epirubicin Liposomes and Invitro Release Rate

Study on entrapment efficiency, drug release in vitro and stability of Crebanine long circulating liposome

Study on the transport mechanisms of levofloxacin in a model of gastric mucosa in vitro

Preparation and in Vitro Release of Phosphate Tylosin Liposome

Studies on Correlation Between Dissolution in Vitro and Absorption in Vivo of Levofloxacin Tablets

Preparation of Lomefloxacin Starch Microspheres by Incubation Absorption and Entrapping and Their Comparative Study on Their Releases in Vitro

Study on Preparation of Berberine Hydrochloride Liposomes